Troels Bechmann
Herning, 7400, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Natural Killer Cell Activity and Response to Neoadjuvant Treatment in Breast Cancer Patients.
Journal: International journal of molecular sciences
Published: September 12, 2025
ASO Author Reflections: Is Axillary Lymph Node Dissection Always Justified for Residual Axillary Disease in Breast Cancer After Neoadjuvant Chemotherapy?
Journal: Annals of surgical oncology
Published: August 21, 2025
Additional Axillary Disease After Neoadjuvant Chemotherapy for Patients with Clinically Node-Negative but Sentinel Node-Positive Disease.
Journal: Annals of surgical oncology
Published: May 13, 2025
Shared decision making with breast cancer patients - does it work? Results of the cluster-randomized, multicenter DBCG RT SDM trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 05, 2023
Through Clinicians Eyes: Use of an In-consultation Patient Decision Aid in Radiation Treatment for Early Breast Cancer. A Qualitative Study.
Journal: Clinical breast cancer
Published: August 14, 2023
A variability in response of osteoclasts to zoledronic acid is mediated by smoking-associated modification in the DNA methylome.
Journal: Clinical epigenetics
Published: October 25, 2022
Shared decision making with breast cancer patients: impact on patient engagement and fear of recurrence. Protocol for a Danish randomized trial in radiotherapy (DBCG RT SDM).
Journal: Acta oncologica (Stockholm, Sweden)
Published: May 19, 2021
Zoledronic Acid Is Not Equally Potent on Osteoclasts Generated From Different Individuals.
Journal: JBMR plus
Published: June 24, 2020
The impact of shared decision making on time consumption and clinical decisions. A prospective cohort study.
Journal: Patient education and counseling
Published: June 12, 2020
Last Updated: 09/26/2026